Assessment of reperfusion following thrombolysis with mean fibrillation and amplitude spectrum area in patients with sustained ventricular fibrillation.

Abstract

BACKGROUND:

Improved microcirculatory reperfusion in patients with ventricular fibrillation (VF) enhances the electrical activity of the fibrillation process and increases the likelihood of successful defibrillation.

METHODS:

Changes in amplitude spectrum area (AMSA) and mean fibrillation (MF) in patients with sustained VF were analysed after administration of rt-PA variant tenecteplase in out-of-hospital cardiac arrest (OHCA) during cardiopulmonary resuscitation (CPR).

RESULTS:

A total of 69 ECG sequences from nine patients were evaluated. Patients who received tenecteplase showed significantly longer duration of VF (p = 0.016). While AMSA declined significantly during CPR (p = 0.001), MF did not differ between groups. There were two survivors in the treatment group and one in the control group.

CONCLUSION:

When tenecteplase was administered during CPR, VF lasted significantly longer than in controls. Changes in MF and AMSA did not indicate improved myocardial perfusion in patients who received tenecteplase during CPR.

• Authors: W Lederer, C J Schlimp, E-M Ritter, T Niederklapfer, M Baubin, A Amann
• Journal: Journal of medical engineering & technology (J Med Eng Technol) Vol. 34 Issue 2 Pg. 148-53 (Feb 2010) ISSN: 1464-522X [Electronic] England
• PMID: 20050762 (Publication Type: Journal Article)

Topics

• Aged
• Aged, 80 and over
• Cardiopulmonary Resuscitation
• Electrocardiography (methods)
• Humans
• Male
• Middle Aged
• Myocardial Reperfusion
• Thrombolytic Therapy (methods)
• Ventricular Fibrillation (pathology, therapy)